Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-060775

Chief Executive Officer acquired 33,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2021-10-15 Option exercise +33,000 $1.81 $59,730 219,932 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2021-10-15 Grant or award · Stock Option (Right to Buy) +43,000 43,000 D
Kulkarni Samarth Chief Executive Officer 2021-10-15 Option exercise · Stock Option (Right to Buy) −33,000 75,983 D
Loading xslF345X03/doc4.xml…